Detalhe da pesquisa
1.
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Nature
; 519(7543): 366-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762141
2.
Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
Am J Med Genet A
; 170(6): 1455-61, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992069
3.
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
Support Care Cancer
; 24(10): 4365-75, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271867
4.
Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
Conn Med
; 80(9): 529-532, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29772136
5.
Kikuchi-Fujimoto Disease in aYoung African American Male: Are we Seeing a Paradigm Shift in Disease Epidemiology? A Case Report.
Conn Med
; 80(7): 409-412, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29782128
6.
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.
Oncologist
; 20(7): 727-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025933
7.
Dual HER2 Blockade in Non-Small Cell Lung Cancer Harboring a HER2 Mutation.
Conn Med
; 79(9): 531-5, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26630704
8.
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
Blood
; 118(11): 3003-12, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768296
9.
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
J Neurooncol
; 114(1): 135-40, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686298
10.
Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Clin Cancer Res
; 29(1): 11-29, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972437
11.
Bevacizumab and daily temozolomide for recurrent glioblastoma.
Cancer
; 118(5): 1302-12, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792866
12.
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.
Cancer
; 118(19): 4759-67, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371319
13.
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
J Natl Compr Canc Netw
; 10(6): 695-9, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22679114
14.
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
J Neurooncol
; 107(1): 213-21, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21997879
15.
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.
J Neurooncol
; 107(1): 155-64, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21986722
16.
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.
J Neurooncol
; 108(3): 499-506, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22407177
17.
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
J Neurooncol
; 109(1): 63-70, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22535433
18.
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
J Neurooncol
; 106(2): 409-15, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21938530
19.
Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.
Neurocrit Care
; 16(1): 109-13, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21882056
20.
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Cancer Cell
; 40(11): 1358-1373.e8, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379208